Naveen Pemmaraju Selected Research

Naveen Pemmaraju Research Topics

Disease

64	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 08/2011
63	Neoplasms (Cancer) 10/2022 - 10/2013
22	Primary Myelofibrosis (Myelosclerosis) 06/2022 - 09/2014
16	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2022 - 01/2015
15	Leukemia 01/2022 - 01/2015
13	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 07/2012
10	Hematologic Neoplasms (Hematological Malignancy) 05/2022 - 01/2017
10	Philadelphia Chromosome 01/2022 - 02/2015
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 12/2014
8	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2018
7	Exanthema (Rash) 01/2021 - 11/2015
6	Fibrosis (Cirrhosis) 06/2022 - 07/2018
6	Infections 08/2021 - 11/2015
6	Residual Neoplasm 01/2021 - 12/2014
5	Anemia 01/2022 - 09/2014
5	Cytopenia 01/2022 - 10/2018
5	Capillary Leak Syndrome 12/2021 - 01/2019
5	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2021 - 10/2013
5	Pathologic Complete Response 07/2020 - 11/2015
4	Disease Progression 06/2022 - 01/2018
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2021 - 01/2019
4	Acute Promyelocytic Leukemia 01/2021 - 08/2013
4	Fatigue 01/2021 - 01/2017
4	Nausea 01/2020 - 02/2015
3	Hypoalbuminemia 10/2022 - 01/2019
3	Edema (Dropsy) 12/2021 - 01/2019
3	Blast Crisis (Blast Phase) 01/2021 - 11/2020
3	Hypertension (High Blood Pressure) 12/2020 - 11/2015
3	Pleural Effusion (Pleural Effusions) 01/2020 - 01/2014
3	Splenomegaly 01/2019 - 10/2014
3	Hemorrhage 12/2018 - 01/2015
3	Pancreatitis 12/2018 - 11/2015
2	Febrile Neutropenia 08/2021 - 01/2018
2	Neutropenia 01/2021 - 01/2021
2	COVID-19 01/2021 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 01/2019
2	Hyperglycemia 01/2020 - 02/2015
2	Diarrhea 01/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

26	venetoclaxIBA 11/2022 - 01/2017
15	ruxolitinibIBA 06/2022 - 03/2015
13	tagraxofuspIBA 10/2022 - 07/2014
13	Decitabine FDA Link 01/2022 - 09/2015
12	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2022 - 11/2013
11	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 01/2015
10	Tyrosine Kinase InhibitorsIBA 01/2022 - 07/2012
7	Dasatinib (BMS 354825)FDA Link 11/2020 - 07/2012
6	Janus Kinase InhibitorsIBA 01/2022 - 01/2015
6	Hemoglobins (Hemoglobin)IBA 01/2022 - 09/2014
5	Transaminases (Aminotransferases)IBA 10/2022 - 02/2015
5	Pharmaceutical PreparationsIBA 01/2022 - 09/2015
5	Core Binding Factors (Core-Binding Factor)IBA 01/2022 - 04/2016
5	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 11/2021 - 07/2014
5	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 08/2021 - 11/2013
5	Clofarabine (Clolar)FDA Link 01/2021 - 11/2013
4	Cladribine FDA LinkGeneric 11/2022 - 01/2014
4	Rituximab (Mabthera)FDA Link 12/2021 - 02/2015
4	Vincristine (Oncovin)FDA LinkGeneric 12/2018 - 02/2015
4	ponatinibIBA 12/2018 - 09/2015
3	navitoclaxIBA 06/2022 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2017
3	CytokinesIBA 06/2022 - 10/2019
3	fms-Like Tyrosine Kinase 3IBA 01/2022 - 07/2014
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 10/2019
3	InterferonsIBA 01/2022 - 12/2020
3	NivolumabIBA 12/2021 - 01/2019
3	fludarabineIBA 12/2021 - 11/2017
3	ibrutinibIBA 12/2021 - 01/2019
3	Alanine Transaminase (SGPT)IBA 08/2021 - 11/2015
3	Inotuzumab OzogamicinIBA 01/2021 - 01/2018
3	Lenalidomide (CC 5013)FDA Link 01/2021 - 01/2015
3	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 01/2019
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2019 - 11/2015
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2017
3	BilirubinIBA 12/2018 - 02/2015
3	Prednisone (Sone)FDA LinkGeneric 12/2018 - 09/2014
3	Janus KinasesIBA 01/2017 - 01/2015
3	Imatinib Mesylate (Gleevec)FDA Link 11/2016 - 07/2012
3	nilotinib FDA Link 11/2016 - 07/2012
2	Alanine (L-Alanine)FDA Link 10/2022 - 10/2019
2	Reticulin (Reticular Fiber)IBA 01/2022 - 10/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 12/2016
2	Immunotoxins (Immunotoxin)IBA 11/2021 - 01/2020
2	COVID-19 VaccinesIBA 05/2021 - 01/2021
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 01/2019
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021 - 01/2021
2	ArsenicIBA 01/2021 - 08/2013
2	Phosphotransferases (Kinase)IBA 12/2020 - 01/2017
2	Biological ProductsIBA 12/2020 - 09/2013
2	nelarabine (506U78)FDA Link 11/2020 - 01/2018
2	ofatumumab FDA Link 07/2020 - 01/2020
2	midostaurinIBA 11/2019 - 08/2019
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2019 - 08/2013

Therapy/Procedure

74	Therapeutics 10/2022 - 07/2012
30	Drug Therapy (Chemotherapy) 05/2022 - 08/2011
6	Immunotherapy 05/2022 - 01/2017
4	Induction Chemotherapy 01/2022 - 01/2016
4	Stem Cell Transplantation 01/2021 - 05/2015
3	Drug Tapering 01/2020 - 01/2018
2	Cell Transplantation 01/2022 - 03/2019
2	Salvage Therapy 01/2021 - 06/2013